Published in J Neurol on April 11, 2007
Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int (2009) 5.43
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet (2009) 4.97
UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production. Proc Natl Acad Sci U S A (2010) 1.57
Vitamin D: A Narrative Review Examining the Evidence for Ten Beliefs. J Gen Intern Med (2016) 1.52
The high prevalence of vitamin D insufficiency across Australian populations is only partly explained by season and latitude. Environ Health Perspect (2007) 1.50
Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One (2009) 1.50
Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am J Clin Nutr (2008) 1.49
Does vitamin D affect risk of developing autoimmune disease?: a systematic review. Semin Arthritis Rheum (2010) 1.39
Vitamin D and multiple sclerosis: an update. Nutr Rev (2008) 1.25
The causal cascade to multiple sclerosis: a model for MS pathogenesis. PLoS One (2009) 1.18
Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis. PLoS One (2010) 1.08
Clinical implications of a possible role of vitamin D in multiple sclerosis. J Neurol (2009) 1.08
Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. Int J Mol Sci (2012) 1.04
Vitamin D, invariant natural killer T-cells and experimental autoimmune disease. Proc Nutr Soc (2012) 1.03
Cholecalciferol plus calcium suppresses abnormal PBMC reactivity in patients with multiple sclerosis. J Clin Endocrinol Metab (2011) 1.02
Human skin pigmentation, migration and disease susceptibility. Philos Trans R Soc Lond B Biol Sci (2012) 1.01
Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial. Trials (2012) 1.00
Confirmation of association between multiple sclerosis and CYP27B1. Eur J Hum Genet (2010) 0.99
Vitamin D in African Americans with multiple sclerosis. Neurology (2011) 0.98
Predominance of Th2 polarization by vitamin D through a STAT6-dependent mechanism. J Neuroinflammation (2011) 0.98
The influence of nutritional factors on the prognosis of multiple sclerosis. Nat Rev Neurol (2012) 0.97
Vitamin D levels in an Australian population. BMC Public Health (2014) 0.95
Prevention and treatment of MS: studying the effects of vitamin D. Mult Scler (2011) 0.95
Is multiple sclerosis an autoimmune disease? Autoimmune Dis (2012) 0.94
Therapies for multiple sclerosis: considerations in the pediatric patient. Nat Rev Neurol (2011) 0.93
Epidemiology of multiple sclerosis in Qom: Demographic study in Iran. Iran J Neurol (2013) 0.92
Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation. Ther Adv Neurol Disord (2012) 0.91
Bone health in multiple sclerosis. Osteoporos Int (2011) 0.90
Complementary and alternative medicine for the treatment of multiple sclerosis. Expert Rev Clin Immunol (2010) 0.89
Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis. Ther Adv Neurol Disord (2013) 0.89
Multiple sclerosis, vitamin D, and HLA-DRB1*15. Neurology (2010) 0.88
Low levels of vitamin D in neuromyelitis optica spectrum disorder: association with disease disability. PLoS One (2014) 0.85
Predictors and prevalence of low bone mineral density in fully ambulatory persons with multiple sclerosis. J Neurol (2009) 0.84
Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population-based case-control study. PLoS One (2012) 0.82
Vitamin D levels in Hispanics with multiple sclerosis. J Neurol (2012) 0.81
Update in vitamin D and multiple sclerosis. Neurosciences (Riyadh) (2015) 0.81
Vitamin D hormone: a multitude of actions potentially influencing the physical function decline in older persons. Geriatr Gerontol Int (2010) 0.81
Illuminating vitamin D effects on B cells - the multiple sclerosis perspective. Immunology (2016) 0.81
NKT cells can help mediate the protective effects of 1,25-dihydroxyvitamin D3 in experimental autoimmune encephalomyelitis in mice. Int Immunol (2015) 0.80
Biologically efficient solar radiation: Vitamin D production and induction of cutaneous malignant melanoma. Dermatoendocrinol (2013) 0.80
Effect of high-dose vitamin D3 intake on ambulation, muscular pain and bone mineral density in a woman with multiple sclerosis: a 10-year longitudinal case report. Int J Mol Sci (2012) 0.78
Historical changes of seasonal differences in the frequency of multiple sclerosis clinical attacks: a multicenter study. J Neurol (2012) 0.78
Vitamin d and multiple sclerosis: correlation, causality, and controversy. Autoimmune Dis (2010) 0.78
Vitamin D and Diabetic Complications: True or False Prophet? Diabetes Ther (2016) 0.78
Association between vitamin D levels and allergy-related outcomes vary by race and other factors. J Allergy Clin Immunol (2015) 0.78
Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosis. Neurol Res Int (2011) 0.78
What is needed to keep persons with multiple sclerosis vitamin D-sufficient throughout the year? J Neurol (2012) 0.77
Is serum vitamin D levels associated with disability in patients with newly diagnosed multiple sclerosis? Iran J Neurol (2013) 0.77
Serum vitamin d levels in Indian patients with multiple sclerosis. Indian J Clin Biochem (2012) 0.77
A reconstruction of a medical history from administrative data: with an application to the cost of skin cancer. Health Econ Rev (2015) 0.77
25-Hydroxyvitamin D levels in acute monosymptomatic optic neuritis: relation to clinical severity, paraclinical findings and risk of multiple sclerosis. J Neurol (2015) 0.76
Can vitamin d suppress endothelial cells apoptosis in multiple sclerosis patients? Int J Prev Med (2013) 0.76
Comparison of Antioxidant Status and Vitamin D Levels between Multiple Sclerosis Patients and Healthy Matched Subjects. Mult Scler Int (2014) 0.76
Evidence for the Importance of Vitamin D Status in Neurologic Conditions. Curr Treat Options Neurol (2015) 0.76
Calcium-phosphate metabolism in patients with multiple sclerosis. J Endocrinol Invest (2015) 0.75
Vitamin D supplementation in the management of knee osteoarthritis: study protocol for a randomized controlled trial. Trials (2012) 0.75
North-South gradients of melanomas and non-melanomas: A role of vitamin D? Dermatoendocrinol (2013) 0.75
Influence of Diet in Multiple Sclerosis: A Systematic Review. Adv Nutr (2017) 0.75
Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: A case-control study. Iran J Neurol (2015) 0.75
Comparison of serum vitamin D level in multiple sclerosis patients, their siblings, and healthy controls. Iran J Neurol (2015) 0.75
Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up. PLoS One (2016) 0.75
A comparison of the direct medical costs for individuals with or without basal or squamous cell skin cancer: A study from Australia. SAGE Open Med (2016) 0.75
Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis. Eur J Clin Nutr (2016) 0.75
Environmental factors influencing multiple sclerosis in Latin America. Mult Scler J Exp Transl Clin (2017) 0.75
Genome-wide association study of vitamin D levels in children: replication in the Western Australian Pregnancy Cohort (Raine) study. Genes Immun (2014) 0.75
Multiple sclerosis: long time modifications of seasonal differences in the frequency of clinical attacks. Neurol Sci (2011) 0.75
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology (1983) 40.64
New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol (1983) 26.67
Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr (1999) 6.64
Effect of Vitamin D on falls: a meta-analysis. JAMA (2004) 6.64
Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr (2005) 6.32
Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr (2004) 6.02
Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA (2005) 5.95
Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr (2001) 4.83
Vitamin D intake and incidence of multiple sclerosis. Neurology (2004) 4.39
Recovery from hip fracture in eight areas of function. J Gerontol A Biol Sci Med Sci (2000) 4.19
Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res (2003) 4.15
The evolution of human skin coloration. J Hum Evol (2000) 4.07
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology (2005) 3.45
1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A (1996) 2.95
Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr (1998) 2.72
Structure-function relationships in the vitamin D endocrine system. Endocr Rev (1995) 2.54
MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology (1988) 2.52
McCollum Award Lecture, 1994: vitamin D--new horizons for the 21st century. Am J Clin Nutr (1994) 2.23
1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest (1991) 2.17
Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ (2003) 2.12
Fracture history and bone loss in patients with MS. Neurology (1998) 1.97
Calcium, vitamin D, milk consumption, and hip fractures: a prospective study among postmenopausal women. Am J Clin Nutr (2003) 1.84
Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol (2003) 1.74
Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem (1992) 1.61
High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology (1994) 1.54
25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult Scler (2005) 1.53
Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses (1986) 1.52
Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromsø study. J Neurol (2005) 1.49
Sunlight--can it prevent as well as cause cancer? Cancer Res (1995) 1.48
A neurologic rating scale (NRS) for use in multiple sclerosis. Neurology (1984) 1.24
Genetic analysis of vitamin D related genes in Canadian multiple sclerosis patients. Canadian Collaborative Study Group. Neurology (2000) 1.23
Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol (2000) 1.18
Vitamin D intake and vitamin D status of Australians. Med J Aust (2002) 1.12
Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. J Neurol Sci (1999) 1.11
Assessment of habitual sun exposure in adolescents via questionnaire--a comparison with objective measurement using polysulphone badges. Melanoma Res (1996) 1.10
The use of spectrophotometry to estimate melanin density in Caucasians. Cancer Epidemiol Biomarkers Prev (1998) 1.05
Clinical aspects of fatigue in multiple sclerosis. Funct Neurol (1998) 1.01
What affects your MS? Responses to an anonymous, Internet-based epidemiological survey. Mult Scler (2004) 0.96
Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles. J Neurol Sci (2000) 0.96
Melanin density and melanin type predict melanocytic naevi in 19-20 year olds of northern European ancestry. Melanoma Res (2000) 0.81
Data collection guidelines for questionnaires to be used in case-control studies of multiple sclerosis. Neurology (1997) 0.79
Contribution of risk factor changes to the decline in coronary incidence during the North Karelia project: a within-community analysis. Int J Epidemiol (1989) 0.78
Phenotypic analysis of antigen-specific T lymphocytes. Science (1996) 24.26
The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell (1986) 14.96
Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med (1997) 12.26
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science (1998) 12.05
Common west African HLA antigens are associated with protection from severe malaria. Nature (1991) 9.43
Cytotoxic T-cell immunity to influenza. N Engl J Med (1983) 8.49
Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature (2001) 7.90
Bias due to misclassification in the estimation of relative risk. Am J Epidemiol (1977) 7.28
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature (1998) 7.12
Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med (2001) 6.51
Standardized mortality ratios and the "healthy worker effect": Scratching beneath the surface. J Occup Med (1976) 6.40
Rapid effector function in CD8+ memory T cells. J Exp Med (1997) 6.36
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med (2000) 5.79
Environmental exposure to lead and children's intelligence at the age of seven years. The Port Pirie Cohort Study. N Engl J Med (1992) 5.49
Factors potentiating the risk of sudden infant death syndrome associated with the prone position. N Engl J Med (1993) 5.48
HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature (1988) 5.45
Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo. J Exp Med (1998) 5.33
Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J (2005) 5.24
A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody. Eur J Immunol (1979) 5.17
Potential impact of global climate change on malaria risk. Environ Health Perspect (1995) 4.44
Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells. Cell (1984) 3.97
Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat Med (1996) 3.94
Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol (1999) 3.79
Excess mortality in England and Wales, and in Greater London, during the 1995 heatwave. J Epidemiol Community Health (1998) 3.67
Cotinine validation of self-reported smoking in commercially run community surveys. J Chronic Dis (1987) 3.54
Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest (1998) 3.53
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology (2005) 3.45
A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J Immunol (1999) 3.36
Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science (2000) 3.20
A human lymphocyte-associated antigen involved in cell-mediated lympholysis. Eur J Immunol (1983) 3.08
Associations of TV viewing and physical activity with the metabolic syndrome in Australian adults. Diabetologia (2005) 3.02
Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. AIDS Res Hum Retroviruses (1996) 3.01
Ecological study of reasons for sharp decline in mortality from ischaemic heart disease in Poland since 1991. BMJ (1998) 2.94
Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc Natl Acad Sci U S A (1991) 2.90
HLA restriction of cell-mediated lysis of influenza virus-infected human cells. Nature (1977) 2.88
Cytotoxic T-cell recognition of HIV proteins and peptides. AIDS (1991) 2.83
A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. AIDS (1999) 2.75
High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. Int Immunol (1990) 2.71
Early effects of climate change: do they include changes in vector-borne disease? Philos Trans R Soc Lond B Biol Sci (2001) 2.71
Evaluation of the Sydney "Quit. For Life" anti-smoking campaign. Part 1. Achievement of intermediate goals. Med J Aust (1986) 2.70
HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi. J Immunol (2000) 2.69
Variability in vitamin D assays impairs clinical assessment of vitamin D status. Intern Med J (2012) 2.67
Evaluation of the Sydney "Quit. For Life" anti-smoking campaign. Part 2. Changes in smoking prevalence. Med J Aust (1986) 2.64
The Hobart Salt Study 1995: few meet national sodium intake target. Med J Aust (1997) 2.62
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology (1999) 2.62
A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17. Hum Immunol (1980) 2.56
A comparison of trends of coronary heart disease mortality in Australia, USA and England and Wales with reference to three major risk factors-hypertension, cigarette smoking and diet. Int J Epidemiol (1980) 2.51
Misconceptions about the use of genetic tests in populations. Lancet (2001) 2.48
Environment and health: 2. Global climate change and health. CMAJ (2000) 2.45
Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. Nature (1997) 2.41
Influenza virus-specific cytotoxic T cells in man; induction and properties of the cytotoxic cell. Eur J Immunol (1978) 2.39
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis. Neurology (2011) 2.39
Declining T-cell immunity to influenza, 1977-82. Lancet (1983) 2.34
An epidemiologic study of mortality within a cohort of rubber workers, 1964-72. J Occup Med (1974) 2.33
Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc Natl Acad Sci U S A (1995) 2.30
Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen. J Immunol (2000) 2.29
Mortality among rubber workers: Relationship to specific jobs. J Occup Med (1976) 2.27
CD8(+) T-cell selection, function, and death in the primary immune response in vivo. J Clin Invest (2000) 2.19
Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst (1980) 2.17
Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. J Gen Virol (1986) 2.16
Uptake and quitting smoking trends in Australia 1974-1984. Prev Med (1987) 2.14
The contribution of changes in the prevalence of prone sleeping position to the decline in sudden infant death syndrome in Tasmania. JAMA (1995) 2.13
Oligoclonal expansions of CD8(+) T cells in chronic HIV infection are antigen specific. J Exp Med (1998) 2.13
Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ (2003) 2.12
Assessing ecosystem health. Trends Ecol Evol (1998) 2.11
HLA B37 determines an influenza A virus nucleoprotein epitope recognized by cytotoxic T lymphocytes. J Exp Med (1986) 2.09
Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology (2011) 2.04
Solvent exposure and leukemia among rubber workers: an epidemiologic study. J Occup Med (1975) 2.00
Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Mult Scler (2006) 1.95
Increased frequency of HLA-Cw3 and HLA-Dw4 in rheumatoid arthritis. Arthritis Rheum (1977) 1.95
Declining blood lead levels and changes in cognitive function during childhood: the Port Pirie Cohort Study. JAMA (1998) 1.95
Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection. AIDS (2000) 1.92
EphA4 (Sek1) receptor tyrosine kinase is required for the development of the corticospinal tract. Proc Natl Acad Sci U S A (1998) 1.91
Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians. Genes Immun (2008) 1.90
An investigation of the effects of daily physical activity on the health of primary school students in South Australia. Int J Epidemiol (1983) 1.89
The Port Pirie cohort study: maternal blood lead and pregnancy outcome. J Epidemiol Community Health (1986) 1.89
Does breastfeeding at six months predict cognitive development? Aust N Z J Public Health (1998) 1.87
HLA class I typing by PCR: HLA-B27 and an African B27 subtype. Lancet (1991) 1.86
Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses. J Clin Invest (2001) 1.85
Short-term associations between outdoor air pollution and mortality in London 1992-4. Occup Environ Med (1999) 1.85
Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk. Neurology (2010) 1.82
Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology (2001) 1.82
BirA enzyme: production and application in the study of membrane receptor-ligand interactions by site-specific biotinylation. Anal Biochem (1999) 1.81
Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis. Lancet (1987) 1.80
Statin therapy, muscle function and falls risk in community-dwelling older adults. QJM (2009) 1.78
Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J Exp Med (1999) 1.77